{"id":"https://openalex.org/W2130154577","doi":"https://doi.org/10.1373/clinchem.2010.146449","title":"Plasma Renin Activity by LC-MS/MS: Development of a Prototypical Clinical Assay Reveals a Subpopulation of Human Plasma Samples with Substantial Peptidase Activity","display_name":"Plasma Renin Activity by LC-MS/MS: Development of a Prototypical Clinical Assay Reveals a Subpopulation of Human Plasma Samples with Substantial Peptidase Activity","alternate_titles":[],"publication_year":2010,"publication_date":"2010-10-01","ids":{"openalex":"https://openalex.org/W2130154577","doi":"https://doi.org/10.1373/clinchem.2010.146449","mag":"2130154577","pmid":"https://pubmed.ncbi.nlm.nih.gov/20739638"},"language":"en","primary_location":{"id":"doi:10.1373/clinchem.2010.146449","doi":"https://doi.org/10.1373/clinchem.2010.146449","is_oa":false,"landing_page_url":"https://doi.org/10.1373/clinchem.2010.146449","pdf_url":null,"source":{"id":"https://openalex.org/S139212996","display_name":"Clinical Chemistry","issn_l":"0009-9147","issn":["0009-9147","1530-8561"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320272","host_organization_name":"American Association for Clinical Chemistry","host_organization_lineage":["https://openalex.org/P4310320272"],"host_organization_lineage_names":["American Association for Clinical Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2130154577"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080913759","display_name":"Cory E. Bystrom","orcid":"https://orcid.org/0000-0003-2015-6216","observed_orcids":["https://orcid.org/0000-0003-2015-6216"]},"institutions":[{"id":"https://openalex.org/I74614422","display_name":"Quest Diagnostics (United States)","ror":"https://ror.org/010g9bb70","country_code":"US","type":"company","lineage":["https://openalex.org/I74614422"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cory E Bystrom","raw_affiliation_strings":["Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA","Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA 92694, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA","institution_ids":["https://openalex.org/I74614422"]},{"raw_affiliation_string":"Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA 92694, USA","institution_ids":["https://openalex.org/I74614422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089801805","display_name":"Wael Antoine Salameh","orcid":"https://orcid.org/0000-0001-5553-5895","observed_orcids":["https://orcid.org/0000-0001-5553-5895"]},"institutions":[{"id":"https://openalex.org/I74614422","display_name":"Quest Diagnostics (United States)","ror":"https://ror.org/010g9bb70","country_code":"US","type":"company","lineage":["https://openalex.org/I74614422"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wael Salameh","raw_affiliation_strings":["Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA","institution_ids":["https://openalex.org/I74614422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108210687","display_name":"Richard E. Reitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I74614422","display_name":"Quest Diagnostics (United States)","ror":"https://ror.org/010g9bb70","country_code":"US","type":"company","lineage":["https://openalex.org/I74614422"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Reitz","raw_affiliation_strings":["Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA","institution_ids":["https://openalex.org/I74614422"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104180175","display_name":"Nigel J. Clarke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I74614422","display_name":"Quest Diagnostics (United States)","ror":"https://ror.org/010g9bb70","country_code":"US","type":"company","lineage":["https://openalex.org/I74614422"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nigel J Clarke","raw_affiliation_strings":["Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quest Diagnostics, Nichols Institute, San Juan Capistrano, CA","institution_ids":["https://openalex.org/I74614422"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5104180175"],"corresponding_institution_ids":["https://openalex.org/I74614422"],"apc_list":{"value":4636,"currency":"USD","value_usd":4636},"apc_paid":null,"fwci":5.1378,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.96030547,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"56","issue":"10","first_page":"1561","last_page":"1569"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasma-renin-activity","display_name":"plasma renin activity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/angiotensin-i","display_name":"angiotensin I","score":0.8519999980926514},{"id":"https://openalex.org/keywords/proteolytic-activity","display_name":"proteolytic activity","score":0.8980000019073486},{"id":"https://openalex.org/keywords/secondary-hypertension","display_name":"secondary hypertension","score":0.6740000247955322},{"id":"https://openalex.org/keywords/lc-ms-ms-method-development","display_name":"LC-MS/MS method development","score":0.8859999775886536},{"id":"https://openalex.org/keywords/multiple-reaction-monitoring","display_name":"multiple reaction monitoring","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7079588770866394},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7062602639198303},{"id":"https://openalex.org/C2779679103","wikidata":"https://www.wikidata.org/wiki/Q5251805","display_name":"Degradation (telecommunications)","level":2,"score":0.577977180480957},{"id":"https://openalex.org/C31827203","wikidata":"https://www.wikidata.org/wiki/Q874296","display_name":"Tandem mass spectrometry","level":3,"score":0.5374636650085449},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.504172682762146},{"id":"https://openalex.org/C172493649","wikidata":"https://www.wikidata.org/wiki/Q7843529","display_name":"Triple quadrupole mass spectrometer","level":5,"score":0.48330259323120117},{"id":"https://openalex.org/C64489805","wikidata":"https://www.wikidata.org/wiki/Q873864","display_name":"Liquid chromatography\u2013mass spectrometry","level":3,"score":0.47406071424484253},{"id":"https://openalex.org/C71043704","wikidata":"https://www.wikidata.org/wiki/Q17144692","display_name":"Selected reaction monitoring","level":4,"score":0.46777239441871643},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.4416666626930237},{"id":"https://openalex.org/C3020134792","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Human plasma","level":2,"score":0.43241795897483826},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.4273143410682678},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09665456414222717},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.06328347325325012},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000803","descriptor_name":"Angiotensin I","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000803","descriptor_name":"Angiotensin I","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010447","descriptor_name":"Peptide Hydrolases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011863","descriptor_name":"Radioimmunoassay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012015","descriptor_name":"Reference Standards","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1373/clinchem.2010.146449","doi":"https://doi.org/10.1373/clinchem.2010.146449","is_oa":false,"landing_page_url":"https://doi.org/10.1373/clinchem.2010.146449","pdf_url":null,"source":{"id":"https://openalex.org/S139212996","display_name":"Clinical Chemistry","issn_l":"0009-9147","issn":["0009-9147","1530-8561"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320272","host_organization_name":"American Association for Clinical Chemistry","host_organization_lineage":["https://openalex.org/P4310320272"],"host_organization_lineage_names":["American Association for Clinical Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Chemistry","raw_type":"journal-article"},{"id":"pmid:20739638","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20739638","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical chemistry","raw_type":"Comparative Study"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1002.5920","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1002.5920","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://clinchem.aaccjnls.org/content/clinchem/early/2010/08/25/clinchem.2010.146449.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7246000170707703}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1819870217","https://openalex.org/W1827617621","https://openalex.org/W1925446680","https://openalex.org/W1929433844","https://openalex.org/W1966117798","https://openalex.org/W2000040025","https://openalex.org/W2014363167","https://openalex.org/W2018622533","https://openalex.org/W2022722223","https://openalex.org/W2038241145","https://openalex.org/W2046753220","https://openalex.org/W2048036605","https://openalex.org/W2058230514","https://openalex.org/W2069352168","https://openalex.org/W2071624868","https://openalex.org/W2102355839","https://openalex.org/W2120418301","https://openalex.org/W2136934622","https://openalex.org/W2154543592","https://openalex.org/W2156903075","https://openalex.org/W2160769763","https://openalex.org/W2345679903","https://openalex.org/W4300912961"],"related_works":["https://openalex.org/W2269869495","https://openalex.org/W4255551092","https://openalex.org/W7211867455","https://openalex.org/W4296501183","https://openalex.org/W2463357675","https://openalex.org/W2122072556","https://openalex.org/W2160769763","https://openalex.org/W2145999509","https://openalex.org/W4313595609"],"abstract_inverted_index":{"BACKGROUND:":[0],"For":[1],"management":[2],"and":[3,35,67,102,129,154,166,195],"treatment":[4],"of":[5,44,61,83,158,170,210,224,248],"secondary":[6],"hypertension,":[7],"plasma":[8],"renin":[9,207],"activity":[10,51,64,234],"(PRA)":[11],"assay":[12],"is":[13,243],"considered":[14],"an":[15,84,193],"essential":[16],"diagnostic":[17],"tool.":[18],"We":[19,150],"developed":[20],"a":[21,41,71,116,218,239],"liquid":[22],"chromatography-tandem":[23],"mass":[24],"spectrometry":[25],"(LC-MS/MS)-based":[26],"approach":[27],"to":[28,98,115,216],"PRA":[29],"offering":[30],"improvements":[31],"in":[32,121,221],"laboratory":[33],"workflow":[34],"throughput.":[36],"During":[37],"development,":[38],"we":[39,68],"observed":[40],"substantial":[42],"number":[43],"clinical":[45,228],"samples":[46,204],"that":[47,242],"have":[48],"strong":[49],"degradation":[50,63,76,86,156,174,233,240],"toward":[52],"angiotensin":[53],"(Ang)":[54],"I":[55,101,160,179,212],"during":[56,181,213],"generation.":[57,182,249],"A":[58],"preliminary":[59],"characterization":[60],"this":[62,75],"was":[65,96,113],"performed,":[66],"provide":[69],"here":[70],"method":[72,185],"by":[73],"which":[74],"can":[77,235],"be":[78,140,217,236],"monitored":[79],"via":[80],"the":[81,110,127,134,173,197,222,246],"addition":[82],"isotope-labeled":[85,162],"standard.":[87],"METHODS:":[88],"Automated":[89],"online":[90],"sample":[91,188],"extraction":[92],"coupled":[93],"with":[94,142,192,205,231],"HPLC":[95],"used":[97],"isolate":[99],"Ang":[100,159,178,211],"internal":[103],"standard":[104,241],"from":[105,109,133,226],"plasma.":[106,148],"The":[107],"effluent":[108],"analytical":[111],"column":[112],"directed":[114],"triple":[117],"quadrupole":[118],"MS":[119],"operated":[120],"selected":[122],"reaction":[123],"monitoring":[124,126],"mode,":[125],"a(5)":[128],"b(5)":[130],"product":[131],"ions":[132],"[M+3H](+3)":[135],"precursors.":[136],"Routine":[137],"analysis":[138],"could":[139],"achieved":[141],"as":[143,145,164],"little":[144],"150":[146],"\u03bcL":[147],"RESULTS:":[149],"identified":[151,237],"both":[152],"C-terminal":[153],"N-terminal":[155],"products":[157],"using":[161,238],"peptides":[163],"controls":[165],"substrates.":[167],"In":[168],"2%-5%":[169],"patient":[171],"samples,":[172],"essentially":[175],"eliminated":[176],"any":[177],"produced":[180],"CONCLUSIONS:":[183],"Our":[184],"requires":[186],"reduced":[187],"handling":[189],"when":[190],"compared":[191],"RIA":[194],"eliminates":[196],"need":[198],"for":[199,203],"extended":[200],"generation":[201,214],"times":[202],"low":[206],"activity.":[208],"Degradation":[209],"appears":[215],"confounding":[219],"variable":[220],"interpretation":[223],"results":[225],"some":[227],"samples.":[229],"Samples":[230],"profound":[232],"added":[244],"at":[245],"start":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2130154577","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
